Clinical trial Recruiting at 1 site Interventional Ages 3 to 7

FES plus task-oriented training for lower-limb function in children with spastic diplegic CP

Official title: Effects of Functional Electrical Stimulation Combined With Task-Oriented Training on Lower Limb Function, Balance, and Quality of Life in Children With Spastic Diplegic Cerebral Palsy.

Run by Lahore University of Biological and Applied Sciences · NCT07924813 · Data updated 2026-11-12

This study tests whether adding Functional Electrical Stimulation to task-oriented training helps 3–7 year olds with spastic diplegic cerebral palsy improve leg function, balance, and quality of life.

Quick facts

Study typeInterventional
Ages3 Years to 7 Years
SexAll
Enrollment44 (estimated)
SponsorLahore University of Biological and Applied Sciences
Academic / other
Locations1 site (Lahore, Punjab Province)
StatusRecruiting
StartedOctober 12, 2026
Main results expectedDecember 30, 2026
Study endsJanuary 2027
Registry record updatedNovember 9, 2026
Trial IDNCT07924813 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 3–7 years with spastic diplegic CP (GMFCS II–III) who can follow simple instructions.

Probably not a fit

Children with conditions or impairments that preclude participation in FES or task-oriented training, or those with recent botulinum toxin treatment or contraindicating medical devices.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this interventional study, 44 children with spastic diplegic cerebral palsy (GMFCS II–III) will be randomized to receive either Functional Electrical Stimulation (FES) plus task-oriented training or task-oriented training alone, three 60-minute sessions per week for six weeks. The FES targets the gluteus medius to support functional movements while participants practice sit-to-stand, standing balance, walking, and related tasks. The trial aims to determine if the combined approach yields greater gains in gross motor function, balance, and quality of life than training alone. Outcomes will inform whether integrating FES into pediatric neurorehabilitation provides added benefit for daily activities and mobility in this population.

Why it matters

Potential benefit: If successful, the approach could offer improved mobility, balance, and overall quality of life for children with spastic diplegic CP.

How similar studies have gone: Previous rehabilitation studies using FES or task-oriented training show promise, but combining both approaches in this pediatric CP subgroup is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Children of either gender, aged 3-7 years, diagnosed with spastic cerebral palsy - Gross Motor Function Classification System (GMFCS) Levels II and III
* Ability to understand and follow simple verbal instructions with or without auditory device

Exclusion Criteria:

* Botulinum toxin injection to the lower limbs within the previous 6 months .
* Severe fixed contractures or musculoskeletal deformities affecting gait .
* Uncontrolled epilepsy or other neurological disorders besides cerebral palsy .
* Cardiac pacemakers or other implanted electrical devices contraindicating FES use.
* Severe visual, auditory, or cognitive impairments preventing participation.

Where it's running

  • Ghurki Trust and Teaching Hospital
    Lahore, Punjab Province, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.